Pregabalin and Elocon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pregabalin (pregabalin) and Elocon (mometasone furoate). Common drug interactions include blindness among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Pregabalin and Elocon. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.
What is Elocon?
Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.
14 people who take Pregabalin and Elocon together, and have interactions are studied.

What are the common drug interactions of Pregabalin and Elocon, by gender? *:
female:
- Blindness
- Tunnel vision (the loss of peripheral vision with retention of central vision)
- Hemiparesis (weakness on one side of the body)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Embolism venous (embolus may pass into the arterial system)
- Psoriasis (immune-mediated disease that affects the skin)
- Purpura (purplish discoloration of the skin)
- Thermal burn (burn by heat)
male:
- Death
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Lip swelling
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Swollen tongue (swelling of tongue)
- Oxygen saturation decreased
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Pneumonia
- Pruritus (severe itching of the skin)
What are the common drug interactions of Pregabalin and Elocon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Purpura (purplish discoloration of the skin)
40-49:
- Blindness
- Tunnel vision (the loss of peripheral vision with retention of central vision)
- Lip swelling
- Swollen tongue (swelling of tongue)
50-59:
n/a
60+:
- Death
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Embolism venous (embolus may pass into the arterial system)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Thermal burn (burn by heat)
- Oxygen saturation decreased
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
What are the existing conditions these people have? *
- Constipation: 4 people, 28.57%
- Insomnia (sleeplessness): 3 people, 21.43%
- Pain: 3 people, 21.43%
- Itching: 3 people, 21.43%
- Delirium (wild excitement): 2 people, 14.29%
- Dyspnea (difficult or laboured breathing): 2 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
- Hepatocellular Carcinoma (liver cancer): 2 people, 14.29%
- Mouth Ulcers: 2 people, 14.29%
- Agitation (state of anxiety or nervous excitement): 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Pregabalin and Elocon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pregabalin (74,069 reports)
- Elocon (2,019 reports)
Browse all drug interactions of Pregabalin and Elocon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Elocon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pregabalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Elocon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on pregabalin and mometasone furoate (the active ingredients of Pregabalin and Elocon, respectively), and Pregabalin and Elocon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tamoxifen Citrate and Azithromycin - 9 seconds ago
- Krill vs. Niacin And Niacinamide, side effect and effectiveness comparison - 13 seconds ago
- Drug interactions of Irbesartan and Tresiba - 15 seconds ago
- Drug interactions of Imodium A-D and Durezol - 15 seconds ago
- Drug interactions of Humulin R and Metoclopramide - 17 seconds ago
- Could Klor-Con cause Radicular Pain? - 22 seconds ago
- Could Captopril cause Cerebral Haemorrhage? - 25 seconds ago
- Drug interactions of Rituxan and Vyvanse - 38 seconds ago
- Could Amrix cause Anxiety Aggravated? - 39 seconds ago
- Could Xanax cause Bronchitis Acute? - 47 seconds ago